Pasithea Therapeutics Corp (KTTA NASDAQ) stock market data APIs
$0.4913
0(0%)
as of October 1, 2026
Try our APIs with
free plan!
Pasithea Therapeutics Corp Financial Data Overview
Price chart is built with
Anychart
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Prev. Close
0.4913
Open
0.4952
High
0.5026
Low
0.4786
52 wk Range
0.281-2.06
Market Cap
16 473 K
Shares Outstanding
33 414 K
Revenue
487 K
EPS
-0.16
Beta
0.33
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pasithea Therapeutics Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pasithea Therapeutics Corp data using free add-ons & libraries
Get Pasithea Therapeutics Corp Fundamental Data
Pasithea Therapeutics Corp Fundamental data includes:
- Net Revenue: 487 K
- EBITDA: -19 138 316
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Pasithea Therapeutics Corp Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pasithea Therapeutics Corp News
New
New Strong Buy Stocks for July 20th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Pasithea Therapeutics Corp. KTTA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its curr...
Pasithea Wins FDA Rare Pediatric Disease Status For PAS-004 To Treat Neurofibromatosis Type 1
(RTTNews) - Pasithea Therapeutics Corp. (KTTA) on Monday said the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation to PAS-004 for the treatment of Neurofibromatosis Typ...
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines
MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generatio...
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock
Extends cash runway through at least the first half of 2028 Led by healthcare-dedicated investors, including Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia Threadneedle Investme...
Get Pasithea Therapeutics Corp fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.